As of 2025-10-28, the Relative Valuation of Inhibrx Inc (INBX) is 1,201.41 USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.85 USD, the upside of Inhibrx Inc based on Relative Valuation is 1941.5%.
The range of the Relative Valuation is (239.07) - 2,747.81 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 15.3x | 14.8x |
| Forward P/E multiples | 14.2x - 15.2x | 14.7x |
| Fair Price | (239.07) - 2,747.81 | 1,201.41 |
| Upside | -506.2% - 4569.2% | 1941.5% |
| Date | P/E |
| 2025-10-27 | -3.51 |
| 2025-10-24 | -3.41 |
| 2025-10-23 | -1.69 |
| 2025-10-22 | -1.88 |
| 2025-10-21 | -2.23 |
| 2025-10-20 | -2.28 |
| 2025-10-17 | -2.22 |
| 2025-10-16 | -2.18 |
| 2025-10-15 | -2.14 |
| 2025-10-14 | -2.07 |
| 2025-10-13 | -2.05 |
| 2025-10-10 | -1.93 |
| 2025-10-09 | -2.08 |
| 2025-10-08 | -2.00 |
| 2025-10-07 | -2.00 |
| 2025-10-06 | -2.08 |
| 2025-10-03 | -2.12 |
| 2025-10-02 | -2.09 |
| 2025-10-01 | -2.02 |
| 2025-09-30 | -2.01 |
| 2025-09-29 | -1.92 |
| 2025-09-26 | -1.95 |
| 2025-09-25 | -1.90 |
| 2025-09-24 | -1.77 |
| 2025-09-23 | -1.72 |
| 2025-09-22 | -1.62 |
| 2025-09-19 | -1.64 |
| 2025-09-18 | -1.59 |
| 2025-09-17 | -1.58 |
| 2025-09-16 | -1.58 |
| 2025-09-15 | -1.62 |
| 2025-09-12 | -1.64 |
| 2025-09-11 | -1.69 |
| 2025-09-10 | -1.65 |
| 2025-09-09 | -1.76 |
| 2025-09-08 | -1.73 |
| 2025-09-05 | -1.68 |
| 2025-09-04 | -1.65 |
| 2025-09-03 | -1.66 |
| 2025-09-02 | -1.65 |
| 2025-08-29 | -1.68 |
| 2025-08-28 | -1.66 |
| 2025-08-27 | -1.63 |
| 2025-08-26 | -1.54 |
| 2025-08-25 | -1.49 |
| 2025-08-22 | -1.49 |
| 2025-08-21 | -1.44 |
| 2025-08-20 | -1.45 |
| 2025-08-19 | -1.37 |
| 2025-08-18 | -1.42 |